Condition
Mesothelioma
Estimated Enrollment: 8
Age Group: 19 Years and older (Adult, Senior)
Gender: All
Study Type: Interventional
Study Design Allocation: Intervention Model: Single Group Assignment|Masking: Open Label|Primary Purpose: Treatment
Study ID Numbers: F090917002 (UAB 0901)|UAB 0901
Study First Received: September 15, 2010
Last Updated: May 20, 2016
Estimated Primary Completion Date: April 2015
Primary Outcome Measures:
Evaluation of the tumor response rate following zoledronic acid|Evaluation of the duration of tumor response
Sponsors and Collaborators:
University of Alabama at Birmingham|Novartis Pharmaceuticals
Website Link: https://ClinicalTrials.gov/show/NCT01204203
